DROPLITE spun out of ICFO in December 2018 after developing for more than four years in ICFO’s KTT Launchpad in collaboration with COSINGO. Their biosensing device was fully developed in house and is a combination of advanced microfluidics, customized chemistry, a proprietary optical detection system, electronics and signal processing. The lab-on-a-chip technology allows a rapid and accurate way to test and monitor health conditions in both humans and animals mainly focused on blood samples.

biomedicine